syl oligosaccarides of IgG that terminate in Nacetylglucosamine. The extent to which the lectin Background. Mannose-binding lectin (MBL), a member of the collectin family, binds to various pathway of complement contributes to overall complement activation in the glomeruli remains unknown, oligosaccharides and activates the classical pathway of complement independent from C1q. At present it but is likely to be marginal. is unknown whether this so-called lectin pathway of
pathway activation is present in IgA nephropathy, Subjects and methods post-streptococcal nephritis and membranoproliferative glomerulonephritis type II. To investigate whether Immunofluorescence MBL and the lectin pathway of complement are also involved in the pathogenesis of certain forms of The renal biopsies of 84 consecutive patients who underwent glomerulonephritis, we investigated deposition of a renal biopsy at the Department of Internal Medicine were MBL in the glomeruli of renal biopsies in patients investigated. As negative controls we used two specimens suffering from various glomerular diseases. In addi-from kidneys which were removed for a renal carcinoma and tion, we measured serum MBL levels in 50 of these one from a patient biopsied because of microhaematuria, who's biopsy was considered completely normal. For patients.
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immunofluorescence studies 5-mm cryostat sections were fixed cases in the glomeruli in a granular pattern along the in acetone and stored at −70°C until investigation. The basement membrane ( Figure 2) . Staining was intense specimens were investigated for deposition of IgG, IgA, IgM, in one patient, moderate in two, and only weak in C1q, C3, terminal complement complex TCC, and MBL seven. Of the five MBL-negative patients two had using the direct immunofluorescence method. The following grade IV disease. They were biopsied after therapy antibodies were applied: anti-MBL, mouse monoclonal anti-with cyclosporin A and were also negative for glomeruli was also detectable in three of 11 patients Routine light microscopy was performed at the Institute with IgA nephropathy. These three cases had a rather of Pathology, Heilbronn Hospital, Heilbronn, Germany.
advanced disease. Of four cases with amyloidosis AL, one also showed segmental MBL deposition. The same Determination of MBL serum levels was observed in two biopsies with advanced renal fibrosis, in which the underlying disease could not be MBL serum levels were measured in 50 patients from whom identified. No MBL deposition was detectable in the a serum sample had been retrieved at the day of renal biopsy, 13 cases of minimal-change disease, three cases of and in five healthy controls. Using the same monoclonal interstitial nephritis or in two patients with idiopathic antibody as for immunofluorescence, an ELISA was perrapidly progressive glomerulonephritis.
formed as described elsewhere [10] . A MBL standard was bought from Statens Serum Institut, Copenhagen, Denmark.
Serum MBL levels Statistical analysis
Serum levels in controls and patients with glomerulonephritis are shown in Table 2 . No difference was
The Kruskal-Wallis non-parametric ANOVA test was used to compare serum MBL levels between the diagnostic groups. observed between controls and the five diagnostic Laboratory results of membranous nephropathy patients groups. In two patients low MBL levels suggestive of with or without glomerular MBL deposition were compared heterozygous MBL deficiency were found. The first by Mann-Whitney U test.
patient with a level of 248 ng/ml suffered from membranoproliferative GN. His glomerular MBL deposition was graded as moderate. The second patient
Results
(serum level 480 ng/ml ) had IgA nephropathy. Both patients were excluded from Table 2 and the statistical Immunofluorescence studies calculations. Of the seven MBL-negative patients with lupus nephropathy, membranoproliferative GN and A complete list of diagnostic groups and the number of MBL-positive cases are shown in Table 1 . All three membranous nephropathy MBL was determined in all but the two patients with membranous nephropathy negative controls were negative for immunoglobulins, complement components and MBL. The most promin-treated with cyclosporin A. In all these patients serum MBL levels were normal. This result excludes hereditent deposits of MBL were evident in lupus nephropathy. All but one case of a class IIa nephropathy ary MBL deficiency as the cause of MBL negativity in their glomeruli. showed deposition of MBL. In three cases staining intensity was graded as intense, in 10 cases as moderate, and in two cases as weak. In general, the staining Comparison of laboratory parameters in membranous intensity was one grade less as compared to C1q. The nephropathy staining pattern was identical to that of immunoglobulins and other complement components, i.e. along Standard laboratory parameters were compared in patients suffering from membranous nephropathy with the basement membrane and in the mesangium in a granular pattern ( Figure 1) . Of the 15 biopsies with or without glomerular MBL deposits ( Table 3) . No statistical difference was observed concerning serum membranous nephropathy MBL was detectable in 10 IgG an IgM and other complement components C1q, C3, and TCC. We suggest that in these patients there is specific binding of MBL via its globular carbohydrate creatinine, C3, C4, proteinuria, and total serum protein, despite the fact that the two stage IV patients in binding domains to certain structures in the glomeruli, and that this binding of MBL does indeed lead to the MBL-negative group were in remission after cyclosporin A treatment. In particular, MBL levels did not cleavage of C4 and C2 via the MBL-associated serine proteases. In contrast, the focal and segmental deposits differ between MBL-positive and MBL-negative 
Our results of normal serum MBL levels suggest, plasma proteins [11] . In these lesions classical pathway components are usually undetectable, and it is therefore that despite MBL deposition of MBL in the glomeruli MBL is not consumed to a great extent in human likely that this entrapment of MBL does not lead to complement activation via the lectin pathway.
glomerulonephritis. Binding to IgG G0 glycoforms could also explain the relatively weak staining of MBL The reason for the very few MBL-negative cases of lupus nephritis, membranous nephropathy (except the when compared to C1q. Based on a frequency of around 20% of IgG G0 glycoforms, an MBL binding two stage IV patients without immunoglobulin deposits) and membranoproliferative GN is unknown. site is expected in 40% of IgG molecules, whereas any IgG molecule has two C1q binding sites. Our results In these patients the amount of MBL in the glomeruli is probably below the detection limit of our method. in patients with IgA nephropathy suggest that MBL does not react with IgA1 deposits in the mesangium. The possibility that these individuals suffer from hereditary MBL deficiency, a condition observed with a In the Japanese study it was suggested that MBL may bind to microbial antigens in the mesangium of some gene frequency of 0.11-0.17 [12] , is excluded by the normal serum MBL levels of these individuals.
patients with IgA nephropathy. We must stress, however, that the proposed mechanisms for MBL deposRecently a study from Japan reported mesangial deposition of MBL and MASP-1 in 25% of patients ition in the glomeruli are by no means proven and require further investigation. with IgA nephropathy, but not in other glomerulopathies [13] . These results seem to be in contrast to ours.
The most important questions arising from our findings are whether MBL in the glomeruli does indeed In that study, however, the number of cases with lupus nephritis, membranous nephropathy, and membrano-activate the lectin pathway of complement, and whether this activation is of any clinical significance proliferative glomerulonephritis was small. The seemingly contrasting results between the studies may compared to classical pathway activation by C1q.
Some aspects stand against an important contribution therefore mainly reflect the difference in the diagnostic categories of the investigated patients. Studies on larger of the lectin pathway. The staining intensity of C1q in the glomeruli is higher compared to MBL. The molar numbers of patients are needed to clarify this issue.
MBL preferentially binds to N-acetylglucosamine, serum concentration of C1q is more than 80 times that of MBL. Despite this fact, serum C1q levels, but not mannose, and fucose [3] . The question arises, therefore, as to which structures in the glomeruli MBL MBL levels, are consistently depressed in lupus nephritis. It appears therefore that much more C1q is binds in lupus nephritis or membranous nephropathy. It has recently been demonstrated that MBL binds to consumed compared to MBL in lupus nephritis. The normal MBL serum levels in membranous nephropathy so-called G0 glycoforms of IgG [14] . IgG has two glycosylation sites on Asn 297 in the CH2 domain and and membranoproliferative glomerulonephritis suggest that MBL is not consumed in these diseases either. We additional glycosylation sites in the variable region with inconstant frequency. The N-linked oligosacchar-also observed no difference in severity of disease between patients suffering from membranous nephroides of human IgG are biantennary, with both branches terminating in galactose (G2 glycoforms) [15] . G0 or pathy with or without glomerular MBL deposits. Based on our observations we propose that MBL is only of agalactosyl glycoforms are oligosaccharide chains that lack terminal galactose on both branches and therefore minor importance in the pathogenesis of human glomerulonephritis. Clearly further investigations are warterminate in N-acetylglucosamine. The frequency of these G0 glycoforms in normal individuals is around ranted to clarify whether the lectin pathway of complement is another player in the complex game of 20%, but increases to 50% in patients with rheumatoid arthritis [16 ] . The terminal N-acetyl glucosamine res-glomerular inflammation in diseases such as lupus nephropathy, membranous nephropathy, membranoidues are accessible to MBL. Binding of MBL to multiple G0 glycoforms fixed on a surface causes proliferative GN type 1, anti-GBM disease, or IgA nephropathy. activation of the lectin pathway of complement [14] . We therefore suggest that MBL binds to G0 glycoforms
